Log in to search using one of your social media accounts:


Biomaterial developed at UCLA helps regrow brain tissue after stroke in mice
A new stroke-healing gel created by UCLA researchers helped regrow neurons and blood vessels in mice whose brains had been damaged by strokes.The finding is reported May 21 in Nature Materials.“We tested this in laboratory mice to determine if it would repair the brain and lead to recovery in a model of stroke,” said Dr. S. Thomas Carmichael, professor of neurology at theDavid Geffen School of Medicine at UCLA. “The study indicated that new brain tissue can be regenerated in what was previously just an inactive brain scar after stroke.”The results suggest that such an approach could some day be used...
Source: UCLA Newsroom: Health Sciences - May 22, 2018 Category: Universities & Medical Training Source Type: news

After Fifty Long Years with Obstetric Fistula, Two Women Reclaim Their Dignity
May 21, 2018They spent most of their lives with the condition, but now two septuagenarians in Mali are healed —and they’re on a mission.en fran çaisThree days.That ’s how long Malado was in labor. That’s how long she was unable to give birth. She was only 16 years old, after all, and it was her first baby. Her body wasn’t ready.This was back in the 1960s in rural Mali, and there were no cars to take her from her village to a health facility —even today, it’s rare to see a car pass on these dirt roads. Finally someone helped her into a donkey-drawn cart and carried her to a c...
Source: IntraHealth International - May 21, 2018 Category: International Medicine & Public Health Authors: mnathe Source Type: news

NaviGate touts “ excellent ” valvular function at 1 year with Gate tricuspid valve
NaviGate Cardiac Structures Inc today touted that the first patient to receive its Gate tricuspid valved stent through a transjugular access procedure under compassionate use protocols has reached one year post-procedure and still maintains excellent valvular function. The procedure was performed last April at the Cleveland Clinic, the Lake Forest, Calif.-based company said. At one year, the patients’ bioprosthesis is demonstrating “excellent leaflet mobility and valve function,” NaviGate said. A total of 16 patients have been treated with the valve for severe tricuspid regurgitation, the company sai...
Source: Mass Device - May 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiac Implants Cardiovascular Replacement Heart Valves NaviGate Cardiac Structures Inc Source Type: news

Does anterior cruciate ligament reconstruction affect the outcome of osteochondral allograft transplantation? A matched cohort study with a mean follow-up of 6 years - T írico LEP, McCauley JC, Pulido PA, Bugbee WD.
BACKGROUND: Few studies have evaluated the influence of anterior cruciate ligament (ACL) reconstruction on the outcome of cartilage repair. Hypothesis/Purpose: The purpose was to investigate the association between ACL reconstruction and functional outcome... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Tanzania:Muhimbili Hospital Detains an Infant's Body for Two Days Over a U.S.$263 Bill
[Citizen] Dar es Salaam -Ms Hamida Gwota gave birth through caesarean section at Muhimbili National Hospital on May 7 this year. Her child was born with gastroschisis, a birth defect where the child's intestines are found outside. Unfortunately, Hamida's child died five days later, on May 12. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 21, 2018 Category: African Health Source Type: news

CoreMedic launches first-in-human study of ChordArt mitral repair device
German medtech developer CoreMedic this week announced the launch of a first-in-man trial of its ChordArt mitral valve repair device, touting the trial as the first of its kind to treat patients with ruptured or elongated mitral chords. The company’s ChordArt implant is designed to replace ruptured or elongated mitral chordae and to re-establish the connection of the valve leaflets with the papillary muscle to restore functionality. In the trial, researchers will explore the use of the system in up to 40 patients at six European centers, CoreMedic said. “The first clinical use of ChordArt is a major milestone i...
Source: Mass Device - May 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Clinical Trials coremedic Source Type: news

Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews
This review of 30 Cochrane reviews assessing various interventions, concludes interventions such as antibiotic prophylaxis for caesarean section and hernia repair, administered before the procedures can prevent surgical site infections. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 16, 2018 Category: Consumer Health News Source Type: news

Ancora Takes on FMR and Heart Failure with AccuCinch
Ancora Heart is making a play for the functional mitral regurgitation (FMR) treatment market – which is currently populated by medtech juggernauts Abbott Laboratories and Edwards Lifesciences. The Santa Clara, CA-based company came closer to its goal to participate in the market after it received FDA approval to expand the enrollment for an early feasibility study of the AccuCinch. Ancora Heart said it can now enroll a second group of patients and expand to 15 heart centers across the U.S. “The AccuCinch System is a left ventricular repair technology and it really is a new category and class of therapy,” ...
Source: MDDI - May 15, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Implants Source Type: news

Genetic fixer-uppers may help predict bladder cancer prognosis
(Penn State) Mutations in genes that help repair damage to DNA may aid in predicting the prognosis of patients with bladder and other related cancers, according to researchers, who found that bladder cancer patients who had mutations in their ATM or RB1 genes -- proteins that help repair DNA damage when they're functioning normally -- tended not to live as long as patients without the mutations. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 15, 2018 Category: Cancer & Oncology Source Type: news

Did Boston Scientific Use Counterfeit Plastic in Pelvic Mesh?
Companies that sell implantable transvaginal mesh devices have been fighting massive, multi-district litigation for years as thousands of U.S. women have complained of severe complications after surgery. Now, a scathing 60 Minutes report on the issue has Boston Scientific up in arms. CBS aired the 60 Minutes report Sunday evening, uncovering emails that suggest Boston Scientific knowingly bought counterfeit plastic material from a Chinese supplier to produce the devices and even repackaged the material to hide the fact that it was an imitation product. The show's producers said Boston Scientif...
Source: MDDI - May 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Materials Source Type: news

Neovasc Sales Significantly Down for the Quarter
Neovasc, one of the smaller players in the transcatheter mitral valve replacement (TMVR) space, has seen a huge decrease in revenues, according to results posted in its most recently recorded earnings quarter. The Vancouver-based company said revenues declined by 77% from $339, 922 for the first quarter of 2018 compared to revenues of $1.5 million from the same period in 2017. "Despite a challenging period for our shareholders, we are encouraged by our improved financial position through the receipt of $12.3 million in proceeds from investor-initiated exercises of Series C warrants that were issued during our Nov...
Source: MDDI - May 14, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Implants Source Type: news

#MayoClinicRadio podcast: 5/12/18
Listen: Mayo Clinic Radio 5/12/18 On the Mayo Clinic Radio podcast, Dr. Charanjit Rihal, a cardiologist at Mayo Clinic, discusses aortic valve disease and options for?valve repair and replacement.?Also on the podcast, Dr. Alice Gallo De Moraes, a critical care specialist at Mayo Clinic, explains how Rapid Response Teams help hospitalized patients get critical care [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 14, 2018 Category: Databases & Libraries Source Type: news

CRC Polyps May Allow for Immune Checkpoint Inhibitors in Premalignant Lesions
Colorectal carcinomas in LS patients appear in background of mismatch repair (MMR) deficiency, show a unique immune profile, and response to immunotherapy. (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news

Study identifies receptor that may be targeted to repair the heart after heart attack, cardiac arrest
This study, published in April in the journal Anesthesiology, confirmed the presence of the receptor in rodent hearts, which are similar in composition to human hearts.UCLA HealthDr. Soban Umar“This study clues us in to how we might be able to better help patients heal when they experience heart conditions,” said Dr. Soban Umar, first author of the study and an assistant professor in residence in the  department of anesthesiology and perioperative medicine at the David Geffen School of Medicine at UCLA. “For the first time, we’re finding a particular receptor in the heart th...
Source: UCLA Newsroom: Health Sciences - May 11, 2018 Category: Universities & Medical Training Source Type: news

Surgery for osteoporosis ‘no better for pain relief than injections’
Surgery to repair spinal fractures is no more effective for pain relief than a sham procedure in older patients with osteoporosis, according to researchers in the Netherlands and the US. (Source: Nursing Times)
Source: Nursing Times - May 10, 2018 Category: Nursing Source Type: news

Women's Pelvic Floor Surgery Not Always Long-Term Fix
WEDNESDAY, May 9, 2018 -- Surgery to repair so-called pelvic floor disorder often fails within five years -- but many women still say the procedure improved their quality of life, a new study finds. " We may be at the point where we need to think of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 9, 2018 Category: General Medicine Source Type: news

Medical News Today: Scientists may have found 'best time' to administer chemo drugs
A genome-wide map of busiest DNA repair times could reduce chemotherapy damage to healthy tissue through optimum 24-hour timing of dosage, say researchers. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 9, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Are You Experiencing Emotional Abuse and Not Aware of It?
You may not think you’re in an emotionally abusive relationship or minimize it. You may not consider your partner abusive because they seem caring and loving towards you, until you do not comply. An abusive partner can be extremely loving when you make yourself available to meet all their needs and give them all your undivided attention. In fact, it is when the partner stops meeting the needs of the abuser that the tantrums, tears, insults, silent treatment or other forms of punishment are used to get their way. In many cases, an emotional abuser is co-dependent on their partner to make them happy, and make up for a...
Source: Psych Central - May 9, 2018 Category: Psychiatry Authors: Nancy Carbone Tags: Abuse Codependence Narcissism Personality Relationships & Love Self-Esteem Self-Help Emotional Abuse emotional blackmail Punishment Source Type: news

Surgery for Hip Fx Cuts Mortality in NH Residents With Dementia
WEDNESDAY, May 9, 2018 -- For nursing home (NH) residents with dementia and hip fracture, surgical hip fracture repair is associated with lower mortality, according to a study published online May 7 in JAMA Internal Medicine. Sarah D. Berry, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2018 Category: Pharmaceuticals Source Type: news

Protein deficiency symptoms: Hair loss warning symptom of the condition
PROTEIN is essential for growth and repair in your body. When we don ’t get enough of this vital nutrient we experience protein deficiency symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Protein deficiency symptoms: Not eating enough protein could cause this
PROTEIN is essential for growth and repair in your body. How much protein we need is determined by our size. When we don ’t get enough of this vital nutrient we experience protein deficiency symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - May 9, 2018 Category: Consumer Health News Source Type: news

£ 4 million bid to find therapies that prompt damaged tissues to repair
(University of Edinburgh) Stem cell scientists are to join forces with doctors to investigate methods of promoting tissue repair in the liver, lungs and joints. The £ 4 million ($5.4 million) project led by the University of Edinburgh seeks to better understand the environment in which stem cells grow in the body, known as the niche. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 9, 2018 Category: Biology Source Type: news

Qualitative study on the control of hazardous energy on machinery using lockout and alternative methods - Karimi B, Chinniah Y, Burlet-Vienney D, Aucourt B.
In Canada, like many countries, the national standard and provincial regulations require that workers performing maintenance, repair, and un-jamming activities on machinery must follow lockout procedures. However, the high number of accidents linked to haz... (Source: SafetyLit)
Source: SafetyLit - May 7, 2018 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Scientists discover roadblocks that stop brain white matter healing
NIH-funded study identifies molecule that may prevent repair. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 7, 2018 Category: American Health Source Type: news

Could reading our circadian clocks according to DNA repair optimize chemotherapy?
(University of North Carolina Health Care) For the first time, the lab of Nobel laureate Aziz Sancar measured DNA repair after cisplatin treatment throughout the entire genome of a mammal over the 24-hour circadian cycle. They found DNA repair of normal tissue was most robust predawn and pre-dusk in mice, and these could represent the best times for treatment using the anti-cancer drug cisplatin, though much more work needs to be done. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 7, 2018 Category: Cancer & Oncology Source Type: news

Preclinical M.D. Anderson study suggests ARID1a may be useful biomarker for immunotherapy
(University of Texas M. D. Anderson Cancer Center) Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas M.D. Anderson Cancer Center. The preclinical study suggests that mutations in ARID1a could be beneficial in predicting immunotherapy success. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 7, 2018 Category: Biology Source Type: news

Scientists discover roadblocks that stop brain white matter healing
(NIH/National Institute of Neurological Disorders and Stroke) A new study identifies a molecule that may be critical to the repair of white matter, the fatty tissue wrapped around parts of brain cells that helps speed up communication. New findings suggest that the molecule triggers a pathway that is normally used by the immune system to prevent excessive damage but may contribute to chronic white matter injury by completely blocking repair operations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2018 Category: International Medicine & Public Health Source Type: news

Nursing home residents with advanced dementia have lower mortality rate with hip surgery
(Hebrew SeniorLife Institute for Aging Research) Researchers from Hebrew SeniorLife's Institute for Aging Research and Brown University have conducted the first study to examine outcomes in nursing home residents with advanced dementia and hip fracture. They discovered that advanced dementia residents have a lower mortality rate after 6 months, if they undergo surgical repair. Those advanced dementia patients managed with surgery also reported less pain and fewer pressure ulcers than those whose proxies chose a palliative care approach in lieu of surgery. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 7, 2018 Category: International Medicine & Public Health Source Type: news

Improving testing and repair of oil and gas pipelines
Novel testing and maintenance methods for oil and gas pipelines developed by EU-funded researchers are helping to ensure the reliability and safety of the extensive pipeline networks that are critical to Europe's energy security. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - May 7, 2018 Category: Research Source Type: news

Intuitive Surgical touts inguinal hernia study
Intuitive Surgical (NSDQ:ISRG) touted a 1,254-patient study today showing that patients who underwent robotic-assisted surgery using the da Vinci system to repair an inguinal hernia had fewer complications after 30 days compared to patients who had open surgery. The study, published in Hernia: The World Journal of Hernia and Abdominal Wall Surgery, was characterized by Intuitive as the largest multi-center comparative study of robotic-assisted and open surgery for inguinal hernia repair. None of the patients in the robotic-assisted surgery group returned for reoperations related to the inguinal hernia repair proc...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Robotics Surgical Wall Street Beat Intuitive Surgical Source Type: news

Endologix promotes COO to corner office, posts mixed Q1 results
Endologix (NSDQ:ELGX) promoted chief operating officer John Onopchenko to CEO just in time for him to take the lead on the company’s first-quarter financial results. Onopchenko served as the Irvine, Calif.-based company’s COO for the past seven months. He has spent 30 years in the medical device industry, including nearly a decade at Johnson & Johnson (NYSE:JNJ), where he led medical device investments and worldwide operations for the company’s advanced sterilization products unit. “Since joining the company as COO, I have been deeply involved in the operations of the organization, and...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: MassDevice Earnings Roundup Stent Grafts Vascular Wall Street Beat Endologix johnsonandjohnson Source Type: news

Abbott wins FDA nod for Advisor HD Gridcardiac mapping cath
Abbott (NYSE:ABT) said today it won FDA clearance for is Advisor HD Grid mapping sensor enabled catheter designed for creating highly detailed maps of the heart. The newly cleared mapping catheter builds on the Abbott Park, Ill.-based company’s previous designs and and is intended to improve cardiac ablation procedures by providing an inside view of the heart for more accurate identification of the cardiac anatomy. The Advisor HD Grid catheter is designed to capture data including the direction and speed of cardiac signals, and allows for the creation of high-density maps of cardiac tissue for more optimal ...
Source: Mass Device - May 3, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Food & Drug Administration (FDA) Regulatory/Compliance Abbott Source Type: news

Opioids Often Over-Prescribed After Hiatal Hernia Surgery
WEDNESDAY, May 2, 2018 -- Patients use fewer opioids than are prescribed after hiatal hernia repair (HHR), according to a study presented at the annual meeting of the American Association for Thoracic Surgery, held from April 28 to May 1 in San... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 2, 2018 Category: Pharmaceuticals Source Type: news

Burn Care: Provider Expertise and Quick Decisions are a Patient ’s Best Chance for Survival
This article will provide an in-depth update of the prehospital care for burn patients. (Source: JEMS Patient Care)
Source: JEMS Patient Care - May 2, 2018 Category: Emergency Medicine Authors: Robert P. Girardeau, BS, NREMT-P, FP-C Tags: Patient Care Source Type: news

Vascugen licenses tech for blood vessel regeneration developed at IU School of Medicine
(Indiana University) Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to disease or injury. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 1, 2018 Category: International Medicine & Public Health Source Type: news

Edwards Lifesciences wins CE Mark for Cardioband transcath tricuspid valve system
Edwards Lifesciences (NYSE:EW) said today it won CE Mark approval in the European Union for its Cardioband transcatheter tricuspid valve reconstruction system, touting it as the first commercially cleared transcath therapy for treating tricuspid heart valve disease. The Cardioband tricuspid system is designed to be delivered through a transfemoral approach and is intended to reduce tricuspid regurgitation through annular reduction, the Irvine, Calif.-baed company said. The system features the same design and implant technique as the company’s Cardioband mitral system. “Although open-heart surgical val...
Source: Mass Device - April 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Regulatory/Compliance Replacement Heart Valves Edwards Lifesciences Source Type: news

3-D-Printed Templates Aid Mandibular Fracture Repair
MONDAY, April 30, 2018 -- A three-dimensional (3-D)-printed short-segment template prototype is feasible for management of complex mandibular fractures, according to a study published online April 26 in JAMA Facial Plastic Surgery. Parul Sinha,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 30, 2018 Category: Pharmaceuticals Source Type: news

4 Trends Advancing Medtech
For the past 20 years, the Medical Design Excellence Awards have celebrated medical products that improve the quality and accessibility of healthcare. Our finalists this year carry on this tradition, while also keeping in step with today’s high-tech digital and consumer trends. With the help of our esteemed jurors, we have identified four key trends in this year’s group of finalists: risk reduction; faster, more-efficient healthcare delivery; the influence of the Internet of Things; and the consumerization of healthcare. We’ve been tracking a few of these trends in past awards programs, so they’re n...
Source: MDDI - April 27, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M East (New York) Design Source Type: news

Post-approval registry shows positive 1-year results for Abbott ’ s MitraClip
A post-approval registry study of the MitraClip mitral valve repair device from Abbott (NYSE:ABT) showed positive results at one year, according to late-breaking results presented this week at the annual meeting of the Society for Cardiovascular Angiography & Interventions in San Diego. The real-world study, of the first 2,000 MitraClip patients treated in the Transcatheter Valve Therapy Registry, showed that 86.8% of patients had post-procedural mitral regurgitation of ≤2+ and a survival rate of 81.7% after a year. Echocardiograms showed improvement in left ventricular end-diastolic volume and left v...
Source: Mass Device - April 27, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Replacement Heart Valves Abbott Source Type: news

Cardiac Dimensions anchors $39m Series B for Carillon mitral repair device
Cardiac Dimensions said today that it raised a $39 million Series B round for the Carillon mitral valve repair device it’s developing. Kirkland, Wash.-based Cardiac Dimensions said the round was led by a new Australian backer, Hostplus, and included a venture debt contribution from Oxford Finance. Existing investors M. H. Carnegie, Arboretum Ventures, Lumira Capital, LSP Health Economics Fund and Aperture Venture Partners also got in on the round, the company said. The percutaneous Carillon annuloplasty device is designed to use a distal anchor and proximal anchor, connected by a shaping ribbon, t...
Source: Mass Device - April 26, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Replacement Heart Valves Wall Street Beat Cardiac Dimensions Inc. Source Type: news

UNISON responds to Lord Darzi ’s interim report on NHS funding
Responding to the interim report published today (Wednesday) by Lord Darzi and the IPPR, on the unprecedented challenges facing the NHS and social care, UNISON head of health Sara Gorton said: “Without substantial extra funding every year, the NHS and social care system will be damaged beyond repair. “The UK won’t have thriving health and social care services while the government persists in robbing the necessary resources. “NHS and social care staff are struggling heroically to keep patients safe and properly looked after. But services and staff are facing unimaginable pressures daily. “As th...
Source: UNISON Health care news - April 26, 2018 Category: UK Health Authors: Charlotte Jeffs Tags: Press release Source Type: news

Study: Silk-based devices with antisense-miRNA therapeutics may enhance bone regeneration
(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers have incorporated therapeutic microRNAs (miRNAs) into bioresorbable, silk-based medical devices such as screws and plates to achieve local delivery of factors that can improve bone growth and mineralization at the site of bone repair. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 24, 2018 Category: Biology Source Type: news

Getting in on the Embolic Protection Action for TAVR
There has been an increase in the need for embolization protection devices as the risk for stroke and other neurological damage from transcatheter aortic valve replacement (TAVR) procedures continues to become more prevalent.   Santa Cruz, CA -based Emboline is looking to enter the embolization protection space, which is set to grow from $406 million this year to $605 million by 2023, according to a report from ResearchandMarkets. The emerging medtech company's contribution to the space would come from its Emboliner Embolic Protection Catheter.  The Emboliner is a cylindrical mesh filter that completely...
Source: MDDI - April 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: Implants Cardiovascular Source Type: news

The Best Spring Superfoods to Fuel Your Workouts
This article originally appeared on Health.com (Source: TIME: Health)
Source: TIME: Health - April 19, 2018 Category: Consumer Health News Authors: Susan Brickell / Health.com Tags: Uncategorized Diet/Nutrition healthytime onetime Source Type: news

HeartStitch wins CE Mark for CoAp Pro mitral valve repair device
HeartStitch said today it won CE Mark approval in the European Union for its CoAp Pro device designed for mitral valve remodeling and repair. The Fountain Valley, Calif.-based company said its CoAp Pro device is designed to allow physicians to remodel mitral valve leaflets to re-establish proper coaptation. “I am especially pleased to see HeartStitch receive this approval, because it provides the ability to use suture to remodel the mitral valves rather than the need to place a prosthetic device in the leaflets. In my opinion it is a significant advancement to the treatment of mitral regurgitation. Personally, I...
Source: Mass Device - April 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Regulatory/Compliance HeartStitch Source Type: news

Spider silk key to new bone-fixing composite
(University of Connecticut) UConn researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 19, 2018 Category: Biology Source Type: news

Gulf Research Program Awards Over $340,000 to Assist Scientific Research Impacted by Hurricanes Harvey and Irma
The Gulf Research Program of the National Academies of Sciences, Engineering, and Medicine today announced 11 grant awards totaling $341,283 to assist in the recovery of Gulf Coast scientific research efforts impacted by hurricanes Harvey and Irma. These awards are the result of the first of two fast-track grant cycles for Scientific Research Disaster Recovery Grants announced last November to help with repair, replacement, or recovery of equipment, data, or other research materials damaged or lost as a result of the hurricanes and their aftermaths. Read More (Source: News from the National Academies)
Source: News from the National Academies - April 18, 2018 Category: Science Source Type: news

Bioelectronic Medicine: Targeting Inflammatory Disease with Electricity
We presented positive initial results in Crohn’s disease at the 2016 United European Gastroenterology meeting: six of the eight patients had seen a substantial reduction in their disease activity index scores, and three were in remission from the disease. As SetPoint looks ahead, several chronic disease areas are emerging as key bioelectronic medicine therapy targets, and our company is exploring a number of these. One of our preclinical programs explores bioelectronic medicine’s potential role as a treatment for MS.   New Target: Multiple Sclerosis In late 2017, SetPoint presented positive data from a s...
Source: Mass Device - April 17, 2018 Category: Medical Devices Authors: Anthony Arnold Tags: Bioelectronic Medicine Clinical Trials Neuromodulation/Neurostimulation SetPoint Medical Sponsored Content Source Type: news

Intact Vascular raises $20m in Series C
Intact Vascular said today it raised $20 million in a Series C round of financing, with funds slated to support the company’s Tack endovascular system through the FDA pre-market approval process. The round was joined by major participants New Enterprise Associates, H.I.G. BioVentures and Quaker Partners, the Wayne, Penn.-based company said. The funding is slated to come in two stages or tranches, with the second closing later this year. Late last week, the company posted an SEC filing showing that it had raised $10 million in a round of mixed financing, and that it was seeking an additional $11.8 million before closi...
Source: Mass Device - April 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Vascular Wall Street Beat Intact Vascular Source Type: news

Ceterix Ortho wins FDA nod for NovoStitch Pro meniscal repair system
Ceterix Orthopaedics said today it won FDA clearance for its next-gen NovoStitch Pro meniscal repair system. The Fremont, Calif.-based company said the newly cleared device is designed to allow surgeons to place stitches arthroscopically in tight joint compartments to treat meniscal tears that had previously been unrepairable. “This FDA clearance is another important milestone in our mission to reduce the number of meniscectomies and to save the meniscus. Ceterix continues to be the leader in meniscal repair by providing innovations that preserve tissue and sustain the natural biomechanics of the knee joint,&rdq...
Source: Mass Device - April 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Orthopedics Regulatory/Compliance Ceterix Orthopaedics Source Type: news